Developing a new assay that will ultimately find commercial success is notoriously complex. To that effect, managing your manufacturing processes in-house may initially appear to be the most streamlined and snag-free route to market. After all, what could benefit your production cycle more than having everything under one roof, ready for immediate analysis, testing and shipping? In reality, overseeing
What are lyophilised reagent beads? Lyophilised reagent beads are durable spheres of freeze-dried material formed from accurately measured dispense volumes of customisable formulation. These single-dose beads – like lyophilised cakes – retain long-term stability at ambient temperature and therefore do not need expensive cold chain shipping or refrigeration during storage. This significantly increases the accessibility of diagnostic testing for difficult-to-reach
Megan, Ish and Georgina are the latest cohort of Laboratory scientists to join us as we continue on our strategic growth journey that will see us become one of the world’s largest and most agile assay contract manufacturers. In November of last year, we announced our relocation into a new, purpose built manufacturing facility and our intention to double
How secure is your assay manufacturing? Manufacturing in vitro diagnostic (IVD) assays in-house, or outsourcing to a single contract manufacturer, should result in the seamless integration of technology transfer, pilot batch production, validation and verification, regulatory submission and subsequently efficient large-scale output. After all, if all those processes are managed in one place the surely there is tighter control? But
Increased throughput, improved efficiency, reduced risk There are many reasons you might consider a new assay manufacturing partner. You may need to ramp up production quickly to meet increasing demand, or you could be looking to reduce production costs. Perhaps you want to mitigate the risk of a single source of supply, or perhaps an issue with an incumbent supplier
We are proud to support the UICC’s World Cancer Day initiative
Our scientific and marketing teams have just completed the finishing touches on our latest whitepaper which outlines the principle benefits of using lyophilised reagent beads to stabilise in vitro diagnostic assays. The 24 Page document explains how the single dose nature of a bead delivers benefits in dosage consistency, speed of reconstitution and reduced risk of contamination and wastage, as
Biofortuna (Deeside UK), a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales. The purpose-built facilities have been designed by the Company to provide the most efficient and modern manufacturing laboratories from which to meet
What are lyophilised reagent beads? Lyophilised reagent beads are durable spheres of freeze-dried material formed from accurately measured dispense volumes of customisable formulation. These single-dose beads – like lyophilised cakes – retain long-term stability at ambient temperature and therefore do not need expensive cold chain shipping or refrigeration during storage. This significantly increases the accessibility of diagnostic testing for difficult-to-reach
Lyophilised reagent beads are durable spheres of freeze-dried material formed from accurately measured and dispensed volumes of customisable formulation. These single-dose beads – like all lyophilised material – retain long-term stability at ambient temperature and therefore do not need expensive cold chain shipping or refrigeration during storage. This significantly increases the accessibility of diagnostic testing for difficult-to-reach patients, facilitating